Cholesterol modulates the interaction between paclitaxel and Langmuir monolayers simulating cell membranes

Area of Science:

• Biophysical chemistry
• Pharmacology
• Materials science

Background:

• Langmuir monolayers serve as simplified models of cell membranes.
• Understanding drug-membrane interactions is crucial for drug development, particularly for antineoplastic agents like paclitaxel.
• Lipid rafts, enriched in cholesterol, play significant roles in cell signaling and drug effects.

Purpose of the Study:

• To investigate how varying cholesterol concentrations in ternary lipid mixtures affect the interaction with paclitaxel.
• To analyze the non-monotonic dependence of paclitaxel's effects on cholesterol concentration in lipid raft models.
• To correlate changes in membrane properties with paclitaxel's modulation.

Main Methods:

• Preparation of Langmuir monolayers composed of dipalmitoylphosphatidylcholine, sphingomyelin, and cholesterol.
• Analysis of surface pressure and compressibility modulus of the monolayers.
• Application of the interactive document mapping (IDMAP) technique to analyze data.
• Studying the effects of the antineoplastic drug paclitaxel on these monolayers.

Main Results:

• Paclitaxel induced maximum surface pressure expansion at 27% cholesterol concentration.
• The compressibility modulus showed the most significant decrease at 48% cholesterol concentration.
• The modulation of paclitaxel's effects by cholesterol concentration was non-monotonic.

Conclusions:

• The concentration of cholesterol in lipid monolayers significantly modulates the effects of paclitaxel.
• Paclitaxel's physiological action may depend on its association with membrane penetration or alterations in membrane elasticity.
• These findings highlight the importance of membrane composition in determining drug efficacy.